Alcon (ALC) vs National Vision (EYE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Alcon (ALC) has outperformed National Vision (EYE) over the past year, losing 3.0% versus a loss of 37.1%. Over five years, ALC leads with a -4.6% price change compared with -65.0% for EYE. Alcon is the larger company by market cap ($35.70 billion vs $1.31 billion), about 27.3 times the size, while National Vision is growing revenue faster (+9.0% vs +4.9%).
On valuation, National Vision trades at a lower forward P/E (14.3x vs 19.1x for Alcon). Alcon pays a dividend yielding 0.48%, while National Vision does not currently pay one. Alcon converts more of its revenue into profit, with a net margin of 9.4% versus 1.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALC | EYE |
|---|---|---|
| Share price | $74.31 | $16.72 |
| Market cap | $35.70B | $1.31B |
| 1-day change | -0.26% | -1.70% |
| YTD return | -5.71% | -35.24% |
| 1-year return | -3.00% | -37.12% |
| 5-year return | -4.62% | -65.00% |
| P/E ratio (TTM) | 54.24 | 20.39 |
| Forward P/E | 19.05 | 14.31 |
| EPS (TTM) | $1.37 | $0.82 |
| Dividend yield | 0.48% | 0.00% |
| Annual dividend | $0.353 | $0.00 |
| Revenue (latest FY) | $10.40B | $1.99B |
| Revenue growth (YoY) | +4.94% | +9.00% |
| Net income (latest FY) | $980.00M | $29.60M |
| Gross margin | 55.24% | 58.77% |
| Operating margin | 13.08% | 2.96% |
| Net margin | 9.42% | 1.49% |
| 52-week high | $87.64 | $30.02 |
| 52-week low | $61.84 | $14.75 |
| Distance from 52-week high | -15.21% | -44.30% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +9.37% | +61.48% |
| Average volume | 2.01M | 2.14M |
| Shares outstanding | 480.40M | 78.07M |
| Employees | 25,000 | 13,138 |
| Sector | Health Care | Health Care |
| Industry | Ophthalmic Goods | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Alcon is about 27.3 times larger than National Vision by market value ($35.70B vs $1.31B).
- ALC has outperformed EYE by 34.1 percentage points over the past year.
- Alcon trades at a higher earnings multiple (54.2x vs 20.4x trailing P/E).
- Alcon is more profitable, keeping 9.4 cents of every revenue dollar as net income versus 1.5 cents for National Vision.
About Alcon
ALC stock →Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide.
Health Care · Ophthalmic Goods · 25,000 employees
About National Vision
EYE stock →National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company offers eyeglasses and contact lenses, and optical accessory products; and provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, Vista Optical military, and DiscountContacts.com.
Health Care · Ophthalmic Goods · 13,138 employees
ALC vs EYE FAQ
Which is bigger, Alcon or National Vision?
Alcon (ALC) is larger, with a market capitalization of $35.70B compared with $1.31B for National Vision (EYE).
Which stock has performed better over the past year, ALC or EYE?
ALC returned -3.00% over the past 12 months, compared with -37.12% for EYE (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ALC or EYE?
EYE has the lower trailing P/E at 20.4, versus 54.2 for ALC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Alcon or National Vision?
Alcon pays a dividend yielding 0.48%, while National Vision does not currently pay a regular dividend.
Are Alcon and National Vision in the same industry?
Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.